Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vedeler

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of the Neurological Sciences|February 1, 1994
Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgGE Ulvestad, K Williams, C Vedeler, et al.
Clinical and Experimental Immunology|January 10, 2003
Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patientsS Sadallah, C Hess, M Trendelenburg, et al.
Journal of Neuroimmunology|November 7, 2000
Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlationsF Romi, G O Skeie, C Vedeler, et al.
Neuroscience Letters|October 20, 1995
Low-affinity nerve growth factor receptor expression in sciatic nerve during P2-peptide induced experimental allergic neuritisG Conti, P L Baron, E Scarpini, et al.
European Journal of Neurology|January 3, 2001
EFNS task force report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Federation of Neurological SocietiesH J Willison, W Ang, N E Gilhus, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controlsA C Kroksveen, A Guldbrandsen, C Vedeler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2001
Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pensionK M Myhr, T Riise, C Vedeler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 1998
Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western NorwayK M Myhr, T Riise, E Barrett-Connor, et al.
Neurology|April 2, 1999
Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple SclerosisK M Myhr, T Riise, F E Green Lilleås, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of the Neurological Sciences|February 1, 1994
Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgGE Ulvestad, K Williams, C Vedeler, et al.
Clinical and Experimental Immunology|January 10, 2003
Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patientsS Sadallah, C Hess, M Trendelenburg, et al.
Journal of Neuroimmunology|November 7, 2000
Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlationsF Romi, G O Skeie, C Vedeler, et al.
Neuroscience Letters|October 20, 1995
Low-affinity nerve growth factor receptor expression in sciatic nerve during P2-peptide induced experimental allergic neuritisG Conti, P L Baron, E Scarpini, et al.
European Journal of Neurology|January 3, 2001
EFNS task force report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Federation of Neurological SocietiesH J Willison, W Ang, N E Gilhus, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controlsA C Kroksveen, A Guldbrandsen, C Vedeler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2001
Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pensionK M Myhr, T Riise, C Vedeler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 1998
Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western NorwayK M Myhr, T Riise, E Barrett-Connor, et al.
Neurology|April 2, 1999
Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple SclerosisK M Myhr, T Riise, F E Green Lilleås, et al.
Pageof 4